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Abstract
Background: Photodynamic therapy (PDT) contains a photosensitizing process, which includes cellular uptake
of photosensitizer and delivery of light to the target. ATP-binding cassette subfamily G2 (ABCG2) regulates
endogenous protoporphyrin levels. In human colon cancers, it is not fully examined the role of ABCG2 in
porphyrin-based photodynamic therapy.
Methods: SW480 and HT29 cells were selected because they showed low and high ABCG2 expression levels,
respectively. Pyropheophorbid-a (PPa) was used as a photosensitizer. Cells were exposed to a 670 nm diod laser.
Cell viability and necrosi apoptosis was examined. Production level of singlet oxygen was detected with the
photomultiplier-tube s/ -based singlet oxygen detection system.
Results: SW480 cells, which expressed lower level of ABCG2, showed the higher uptake of PPa than HT-29 cells. The
uptake level of PPa was significantly correlated with the decreased cell viability after PDT. Pretreatment with a ABCG2
inhibitor, Ko-143, significantly enhanced the PDT efficacy in HT29 cells compared to vehicle-pretreated cells. To confirm
the ABCG2 effect on PDT, we established ABCG2 over-expressing stable cells in SW480 cells (SW480/ABCG2).
Furthermore, SW480/ABCG2 cells showed significantly decreased PDT effect compared to the control cells. The increased
or decreased cell survival was significantly correlated with the production level of singlet oxygen after PDT.
Conclusion: ABCG2 plays an important role in determining the PDT efficacy by controlling the photosensitizer efflux
rate. This implies the control of ABCG2 expression may be a potential solution to enhance photosensitivity.
Keywords: Photodynamic therapy, Colon cancer, Protoporphyrin, ATP-binding cassette transporters, Photosensitizing
agents
Background
Photodynamic therapy (PDT) is a modality that uses a
photosensitizer that is selective to target cells, followed
by exposure to a given specific light source [1, 2]. Photo-
sensitizer is excited by irradiation, producing reactive
oxygen species such as singlet oxygen, other free radicals
and cause necrosis or apoptosis of the target cells [3].
PDT is indicated in the treatment of various cancers and
is known to be particularly effective in basal cancer cells
such as skin cancer [4].
Pheophorbide a (PPa) is a chlorophyll-based photosen-
sitizer which is localized to the mitochondria [5]. Many
studies reported that PPa showed an anti-tumor effect in
vivo on human lung, liver, and skin cancer [6–8]. Irradi-
ated PPa produced singlet oxygen which rapidly induced
depolarization of mitochondrial membrane potential and
tumor cell death. PDT using PPa has been attempted on
hepatocarcinoma, Jurkat leukemia cell, pigmented mel-
anoma, and colon cancer cells [9–11]. PPa had structural
similarities with porphyrin which was the most com-
monly used photosensitizer [12].
The main problem in the chemotherapy of cancer is
that drug resistance may occur and such resistance is
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the main reason that makes cancer treatment difficult. One
of the drug resistance mechanisms derived from the drug
efflux system of cells. ATP-binding cassette subfamily G2
(ABCG2) is a family of multi-drug resistance proteins,
which protect cell from exogenous and endogenous toxin
through the efflux system [13]. ABCG2 interacts with heme
structure and porphyrins and block their accumulation in
cells and tissues [14, 15]. Intracellular uptake of photosensi-
tizer is accordingly regulated by ABC transporter superfam-
ily member ABCG2. ABCG2 was regarded as the main
cause of resistance to PDT. Studies with ABCG2 knock-out
mice had shown the accumulation of porphyrin photosenti-
zer and increase in photosensitivity compared to wild type
mice, which means that the ABCG2 protein plays a major
role in PDT efficacy [16]. Also, the overexpression of
ABCG2 induced resistance to PDT by blocking the accu-
mulation of photosensitizer in cell [13]. In colon cancers, a
study reported that the expression of ABCG2 correlated
with the shortened patient survival [17].
In this study, we hypothesized that ABCG2 is a target
protein in enhancing colon cancer PDT efficacy. To con-
firm our hypothesis, we tested PDT effect depending on
ABCG2 expression level. We also checked the results
after the inhibition of ABCG2 with Ko-143. In order to
show that ABCG2 is directly related with PDT efficacy,
we established ABCG2 overexpressing stable cells in
SW480 and tested PDT efficacy in vitro. Furthermore,
we checked the anti-tumor effect on xenograft model
using cells with either low or high expression of ABCG2
cell in vivo. The results from this study show a possible
cause of reduced sensitivity to photosensitizer-PDT in
colon cancer cells. Inhibition of ABCG2 expression may
be a potential solution to enhance photosensitivity.
Methods
Materials
Pheophorbide a (PPa) was obtained from Frontier Scientific
Inc. (USA). Ko-143 and thiazolyl blue tetrazolium
bromide (MTT) were from Sigma Aldrich. Mouse
monoclonal antibodies to ABCG2 and β-actin were
from Santa Cruz (USA). Polyclonal rabbit antibody to
caspase (cleaved) was purchased from abcam (UK).
Polyclonal rabbit antibody to LC3 was purchased from
Cell Signaling Technology (USA).
Cell culture and in vitro photodynamic treatment
SW480, SW480/ABCG2, HT29, HCT116, LoVo, and
DLD1 cells were maintained under an atmosphere of
5 % CO2 in RPMI medium (Genedepot, USA) supple-
mented with 10 % fetal bovine serum and 1 % penicillin-
streptomicin (Genedepot, USA). Cells were incubated
with or without PPa (0–400 nM) for 16 h at 37 °C in
RPMI medium supplemented with 5 % fetal bovine
serum and 1 % penicillin-streptomicin. Ko-143 (0-1uM)
were pretreated or treated for 1 h at 37 °C. The cells
were then photoirradiated using a diod laser emitting
red light at 670 nm wavelength (equipment by Kuk-Je A
& SL Co., Seoul, Korea). The power density at the illu-
mination area was 800 mW/cm2 and total light dose was
4 J/cm2. Thereafter, cells were harvested at 4 h, 8 h, and
24 h, respectively.
Cell viability assay
Cells were cultured in 96-well culture plates (1 × 104cells/
well) overnight. Cells applied to PDT were incubated for
4 h with 0.5 mg/ml thiazolyl blue tetrazolium bromide.
Converted MTT formazan crystals were solubilized
DMSO. The absorbance at 540 nm was measured using
microplate reader (Biotek ELX-800 Absorbance Reader,
USA).
Measurement of Singlet oxygen production
Cells were incubated with or without PPa (0–400 nM)
for 16 h at 37 °C, washed twice in PBS, and lysed in
methanol. Lysed cells were applied to PMT-based singlet
oxygen monitoring system (Physical Sciences Inc., USA).
Quantitative Real-time PCR
Total RNA was isolated with Trizol Reagent (Invitrogen,
USA) and reverse-transcribed with a reverse transcrip-
tion (RT)-PCR kit (Takara) according to manufacturer’s
instruction. The level of ABCG2 was measured using a
MX-3000P (Stratagene, USA). SYBR green master mix
(Takara, Japan) was used to quantify the mRNA expression
of ABCG2. The primers used for quantitative RT-PCR were
as follows: ABCG2 sense, 5’-TGGCTTAGACTCAAGCAC
AGC; ABCG2 antisense, 5’-TCGTCCCTGCTTAGACAT
CC-3; GAPDH sense, 5’-AGCCACATCGCTCAGACAC-
3’; GAPDH antisense, 5’-GCCCAATACGACCAAATCC-3’.
Immunocytochemical assay
Cells were cultured on glass coverslip. Glass coverslips
of confluent cells were washed with PBS two times. Cells
were fixed for 20 min at room temperature in 4 % paraf-
ormalaldehyde/PBS. After rinsing with PBS, cells were
incubated with 5%FBS/PBS for 30 min to block non-
specific staining. After washing with PBS, cells were in-
cubated with ABCG2 antibody in 5%FBS/PBS overnight
(1:200). After washing with PBS, cells were incubated
with secondary Alexa-488 antibody in 5%FBS/PBS for an
hour. Cells were monitored by fluorescence microscopy
(Axiovert 200 MAT, Zeiss, Germany).
Flow cytometry
Cells were applied to PDT and then incubated with
Annexin V-FITC or PI for 15 min at room temperature.
Measurement of apoptosis or necrosis was done using
FACS Calibur flow cytometer (BD Bioscience, USA).
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Immunoblot analysis
Cells lysed in buffer containing 20 mM HEPES (pH 7.0),
1 % Triton X-100, 150 mM NaCl, 10 % glycerol, 2 mM
EGTA, 1 mM EDTA, 1 mM Glycerol 2-phosphate, 1 μg/
ml leupeptin, 1 μg/μl aprotinin, 1 mM AEBSF, 50 mM
NaF, and 1 mM NA3VO4. The proteins separated by
SDS-PAGE were transferred to a nitrocellulose mem-
brane using electrophoresis tank. After the membrane
was incubated with specific antibodies, the signal was
enhanced with chemiluminesence reagents (Genedepot)
and then measured by LAS-3000 Image Analysis System
(Fujifilm, Japan).
Stable cell establishment in SW480 cells using retrovirus
For preparation of SW480/ABCG2, retrovirus encoding
ABCG2 genes were produced by using BglII/XhoI sites.
HEK293T cells were transfected with pMSCV-ABCG2,
pgag-pol, and pVSV-G, using Lipofectamine2000, and
then 48 h later, media including Prx III retroviruses were
collected and filtered to remove cell debris. SW480 cells
were incubated with ABCG2 retrovirus, and the cells
were inoculated with ABCG2 retrovirus. The cells ex-
pressing ABCG2 were selected with puromycin.
Xenograft model and Photodynamic therapy
Four-week-old male BALB/c nude mice were used for
in vivo study. The animal experiments were conducted
in accordance with the institutional guidelines of the
Catholic University of Korea, College of medicine,
Seoul, Korea. SW480 and SW480/ABCG2 cells (0.5 × 106)
were inoculated subcutaneously in 100 μl of phosphate-
buffered saline (PBS). The mice were then divided
into a treatment and a control group. The treatment
group consisted of two subgroups: the control group
and the PDT applied group (670 nm). Animals were
injected i.v. with Ko-143(10 mg/kg) followed by i.v.
PPa after 1 h.
Statistical analysis
Data were expressed as means ± standard error of mean
(SEM) using Student t test.
Results
Differences of PDT effect derived from PPa accumulation
depending on ABCG2 expression level in colon cancer cell
The aim of this study was to see whether ABCG2 is a
target protein in enhancing colon cancer PDT efficacy.
To confirm ABCG2 effect in PDT, we tested ABCG2 ex-
pression level in colon cancer cell lines (Fig. 1a, b). In
colon cancer cells, HT29 cell showed the highest expres-
sion of ABCG2 mRNA and protein. SW480, DLD1,
LOVO, and HCT116 cells showed low expression of
ABCG2. Among them, SW480 cells showed the lowest
ABCG2 mRNA level. SW480 and HT29 cells were se-
lected, which showed the lowest and highest ABCG2 ex-
pression level, respectively, among the tested colon
cancer cells (Fig. 1c). Cells were incubated with PPa for
16 h and then irradiated with 4 J/cm2 red right. There
were differences in the cell survival rate and singlet oxy-
gen production between SW480 and HT29. Cell survival
rate was measured using MTT assay. After PDT, higher
treatment efficacy was obtained in SW480 cells compared
Fig. 1 ABCG2 expression level in colon cancer cell lines. a, Immunoblotting analysis of whole cell lysates of various colon cancer cell lines. b, Total RNA
was isolated from colon cancer cell lines, reverse-transcribed, and quantified by quantitative real-time PCR with the specific primer for ABCG2 and
GAPDH, respectively c, SW480 and HT-29 cell lysates were subjected to immunoblot analysis with indicated antibodies. Values were expressed as fold
change relative to control and were normalized to actin. Data are means ± SEM from three independent experiments (*P < 0.05, **P < 0.01, #P < 0.0001)
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to HT29 (Fig. 2a). After treating with 100 nM PPa, there
was differences of three times in phototoxicity between
SW480 and HT29. Singlet oxygen played a main role in
killing cancer cells in PDT. We checked the singlet oxygen
production using PMT-based singlet oxygen monitoring
system. SW480 cell showed lower production rate of sing-
let oxygen than HT29 (Fig. 2b). These results indicate that
high expression of ABCG2 induced PPa release out of the
cell by the efflux function. To further explain the effect of
ABCG2 in PDT, we verified localization of ABCG2 and
accumulation of PPa using light fluorescence microscopy
(Fig. 2c). SW480 cells showed no fluorescence of ABCG2,
but strong red fluorescence of PPa. In contrast, HT29 cells
showed ABCG2 fluorescence without accumulation of
PPa. These results indicate that ABCG2 is related with the
resistance to PDT derived from the efflux of photosensi-
tizer in colon cancer.
Enhanced efficacy of PDT by ABCG2 inhibition
The above findings proved that ABCG2 plays a major
role in the resistance of PDT, which could be prevented
by using Ko-143, an inhibitor of ABCG2 transporter
[18]. To confirm whether the blockage of ABCG2 could
increase the effect of PDT in colon cancer, we tested the
cell survival rate and singlet oxygen production. Cells
were pretreated with 1 μM of Ko-143 for 1 h and then
incubated with PPa. There was no change in the SW480
cell survival rate after the inhibition of ABCG2 (Fig. 3a).
Contrastingly, HT29 cells showed decreased cell survival
rate derived from ABCG2 protection (Fig. 3a). Com-
bined treatment of PPa with Ko-143 enhanced the sensi-
tivity of HT29 cell to PDT. To further investigate the
ABCG2 inhibition effect, we measured singlet oxygen
production of ABCG2 treated cells and non-treated cells.
Singlet oxygen production rate was increased after-
ABCG2 inhibition in both SW480 and HT29. SW480
cells showed a little increase in the singlet oxygen, with
no effect on cell survival rate. On the other hand, HT29
cells treated with Ko-143 showed more singlet oxygen
production compared to other cells (Fig. 3b). To clarify
that ABCG2 was inversely related with PPa accumula-
tion, we measured fluorescence of PPa in Ko-143treated
cells using fluorescence microscope. The level of PPa
fluorescence in HT29 cells was remarkably increased by
Fig. 2 Differences of PDT effect between SW480 and HT29 cells depending on ABCG2 expression level. a, SW480 and HT29 cells were irradiated
with a PDT laser (4 J/cm2) after a 16 h pretreatment of PPa at indicated concentrations. The MTT assay was performed in triplicate 24 h following
the irradiation. b, Cells were incubated with 100 nM PPa for 16 h and then lysed with methanol, followed by application of PMT-based singlet
oxygen monitoring system. c, Cells were incubated with 200 nM PPa for 16 h and then subjected to immunocytochemical staining for anti-abcg2
(Green), PPa (Red), and DAPI (blue). Data are means ± SEM from three independent experiments (*P < 0.05, **P < 0.01, #P < 0.0001)
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Ko-143 (Fig. 3c). It seems that ABCG2 inhibition in-
creased the sensitivity to PDT by blocking PPa efflux
and thereby inducing high level of singlet oxygen.
Effect of ABCG2 overexpression
As mentioned above, ABCG2 plays a major role in indu-
cing drug resistance and determining the efficacy of
PDT. In order to show that ABCG2 is directly related
with PDT efficacy, we established SW480 that stably
overexpress ABCG2 using retrovirus. The expression
level of ABCG2 in SW480 and SW480/ABCG2 was con-
firmed by western blot analysis and immunocytochem-
istry with anti-ABCG2 antibody (Fig. 4a). SW/ABCG2
cells with overexpression of ABCG2showed higher level
of survival rate compared to SW480 and HT29, which
indicates that overexpression of ABCG2 is directly re-
lated with the efficacy of PDT and drug resistance
(Fig. 4b). SW480/ABCG2 cells showed low fluorescence
of PPa, whereas SW480 cell showed strong signal of PPa
(Fig. 4c). Also, singlet oxygen production rate was de-
creased in SW480/ABCG2 cells (Fig. 5a). To investigate
the effect of PDT on cell viability, we checked for apop-
tosis or necrosis using flow cytometry analysis with
Annexin V and PI. After irradiation, apoptosis and ne-
crosis developed considerably in SW480. SW480 cells
with overexpression of ABCG2 showed little necrosis
while HT29 cells showed some areas of apoptosis and
necrosis (Fig. 5b). In order to verify the effect of ABCG2
on PDT efficacy, we checked for the cleaved caspase-3
and LC3II level. Cleaved caspase-3 is known as a marker
of apoptosis and LC3II suggests autophagic cell death
[19, 20]. Cleaved caspase-3 level in SW480 was further
increased at 24 h after PDT than SW480/ABCG2
(Fig. 5c) and SW480/ABCG2 cells showed low level of
LC3II than SW480 at post-24 h PDT (Fig. 3c). The
above data indicate that ABCG2 expression level in
colon cancer cells is inversely related with PDT efficacy,
and that ABCG2 inhibition could therefore increase can-
cer cell death.
In vivo antitumor effects of PDT
To test for the effects of ABCG2 expression in vivo, PDT
was applied to xenograft tumor models established by sub-
cutaneous injection of colon cancer cells (SW480, SW480/
ABCG2). When tumor size reached150-200 mm3, PPa
was administered to the tumors at the dose of
1.25 mg/kg followed by irradiation with a 670 nm
diode light (150 J/cm2) 6 h later. There was no
change in size of the tumor between SW480 and
SW480/ABCG2 injected mice immediately after PDT.
However, at 7 days after the injection, the tumor volume
increased by a greater extent in mice injected with
Fig. 3 Effect of Ko-143 on PPa treated colon cancer cell in PDT. a, Cells were irradiated by 670 nm light (4 J/cm2) after 16 h incubation with indicated
concentration of PPa in the presence or absence of 1 μM Ko-143. At 24 h after PDT, the MTT assay was performed. b, Cells were incubated with 100 nM
PPa for 16 h in the presence or absence of 1uM Ko-143 and then lysed with methanol, followed by application of PMT-based singlet oxygen monitoring
system. c, Cells were incubated with 200 nM PPa for 16 h in the presence or absence of 1uM Ko-143 and then subjected to immunocytochemical staining
for anti-abcg2 (Green), PPa (Red), and DAPI (blue). Data are means ± SEM from three independent experiments (*P < 0.05, **P < 0.01, #P < 0.0001)
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SW480/ABCG2 cells compared to mice injected with
SW480 cells (Fig. 6a). To confirm this result, HT-29 cells
xenografted in nude mouse were treated with PBS alone,
PPa + irradiation with or without Ko-143 pretreatment
(Fig. 6b). As shown in cell experiments, combined treat-
ment of PPa with Ko-143 enhanced the sensitivity of
HT29 cell to PDT. These results show that ABCG2 ex-
pression influences the outcome of PDT in vivo.
Discussion
In this study, we demonstrated that ABCG2 plays a main
role in drug resistance related to PDT in colon cancer
cell. Our data showed that ABCG2 overexpression
strongly induced photosensitizer efflux which means that
ABCG2 inhibition may be the solution of drug resistance
in colon cancer. Studies indicated that ABCG2 contrib-
utes to protection of cellular accumulation of porphyrin
and toxic heme components [14]. ABCG2 was first dis-
covered in a breast cancer cell line, which is also called
breast cancer resistance protein (BCRP/ABCG2) [21]. It
has been reported that ABCG2 overexpression using
temporarily ABCG2-transfected HEK293 cells showed
decreased cellular accumulation of PPIX, whereas other
ABC-transporter overexpression (ABCB1 and ABCC1)
did not effect on PPIX accumulation, which suggested
that ABCG2 could be the main target of drug resistance
[12]. In human colon cancer cell, ABCG2 is known as
main cause of resistance to drug such as SN-38 which is
used for chemotherapy in colon cancer [22]. ABCG2 is
important in developing drug resistance in PDT. How-
ever, the association ABCG2 and PDT efficacy in colon
cancer cell remain unclear. Our studies demonstrate that
PDT efficacy is regulated by ABCG2 expression level in
colon cancer. First of all, we checked the ABCG2 ex-
pression level in mRNA and protein. We found that high
expression level of ABCG2 cells showed low efficacy of
PDT which was resulted from low accumulation PPa
due to ABCG2 induced efflux. Fluorescence microscopy
experiments also showed low level of PPa in ABCG2
overexpressed cell. Also, ABCG2 inhibitor, Ko-143,
treated cell showed increased PPa accumulation, which
induced high PDT efficacy. Consistently, ABCG2 knock-
down in HT-29 using siRNA showed increased PPa (data
not shown). PDT efficacy was correlated with ABCG2
Fig. 4 Effect of ABCG2 on the uptake of photosensitizer in SW480 and SW480/ABCG2 cells. a, Overexpression of ABCG2 in SW480 was confirmed
by immunoblotting and immunocytochemical assay using ABCG2 antibody. b, MTT assay was performed in SW480 and SW480/ABCG2 cells. c, SW480
and SW480/ABCG2 cells were incubated with 200 nM PPa for 16 h and then immunocytochemical assay for anti-abcg2 (Green), PPa (Red), and DAPI
(blue) was applied. Data are means ± SEM from three independent experiments (*P < 0.05, **P < 0.01, #P < 0.0001)
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Fig. 5 Differences of singlet oxygen production rate & cell death between SW480 and SW480/ABCG2 cells. a, SW480, SW480/ABCG2, and HT29
cells were incubated with 100 nM PPa for 16 h and then lysed with methanol, followed by application of PMT-based singlet oxygen monitoring
system. b, Cells were harvested 4 h after photosensitization and stained with Annexin V/PI for FACS analysis. c, Cells were incubated with 100 nM PPa
for 16 h followed by irradiation. Cell lysates were subjected to immunoblot with indicated antibodies. Data are means ± SEM from three independent
experiments (*P < 0.05, **P < 0.01, #P < 0.0001)
Fig. 6 Antitumor effects of PDT in in vivo experiments. a, SW480 and SW480/ABCG2 cells were collected and subcutaneously injected into BALB/c
nude mice. The sizes of tumors were measured using a caliper, tumor volume was calculated using the formula: 0.523 × length × width2 (mm3).
b, HT-29 cells xenografted in nude mouse were treated with PBS alone, PPa + irradiation with or without Ko-143 pretreatment. Combined treatment of
PPa with Ko-143 enhanced the sensitivity of HT29 cell to PDT. Data are means ± SEM from n = 4 (*P < 0.05, **P < 0.01, #P < 0.0001)
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expression level. SW480/ABCG2 expressing high level of
ABCG2 showed no apoptosis or necrosis after PDT,
whereas, SW480 cells were prone to apoptosis or necro-
sis. These phenomena were also confirmed by higher
level of cleaved caspase-3 and LC3II in SW480 cells.
SW480 treated with PDT showed increased cleaved
caspase-3 and LC3II compared to SW480/ABCG2,
which means that apoptotic and autophagic cell death
was induced in SW480 cells. Tumor cell death in PDT
was induced by the release of singlet oxygen produced
by photo-excitation of photosensitizer by visible light
[23]. We found that singlet oxygen production was corre-
lated with PPa accumulation in cells. These data suggested
that PDT efficacy was dependent on PPa accumulation
and PPa induced singlet oxygen production. According to
recent report, ABCG2, drug transporter, regulates the out-
come of hypericin-mediated photodynamic therapy in
HT-29 [24].
ABCG2 has been already found to have the main role
in porphyrin accumulation in mice. To show ABCG2
directly influenced PDT efficacy, we established SW480
stably overexpressing ABCG2 and also tested PDT effi-
cacy using in vitro system, and then we checked the
anti-tumor effect on xenograft model using cells differ-
ently expressing ABCG2 in vivo studies. The tumor size
of SW480 cells was significantly smaller in the group
treated with PPa-PDT compared to the SW480/ABCG2
injected group. These results indicate that antitumor ef-
fects are dependent on ABCG2 expression level.
Many researchers reported that ABCG2 inhibition had
decreased PDT efficacy through other protein regulation
[25–27]. However, we directly showed ABCG2 effect in
colon cancer cell using ABCG2 overexpressed cell line
both in vitro and in vivo, providing direct evidences of
enhanced PDT effect when inhibiting the ABCG2. In
this aspect, our research suggests a very important role
of ABCG2 in drug resistance and PDT efficacy in colon
cancer cell, and provides reasonable and sufficient evi-
dence to develop ABCG2 inhibitor for protecting drug
resistance.
Conclusion
In summary, this study shows a possible cause of re-
duced sensitivity to photosensitizer-PDT in colon cancer
cells. Our study provides a potential solution to enhance
photosensitivity by inhibition of ABCG2 expression.
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